Cargando…
Current and Future Treatment Strategies for Rhabdomyosarcoma
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children, and can be subcategorized histologically and/or based on PAX-FOXO1 fusion gene status. Over the last four decades, there have been no significant improvements in clinical outcomes for advanced and metastatic RMS patients, und...
Autores principales: | Chen, Celine, Dorado Garcia, Heathcliff, Scheer, Monika, Henssen, Anton G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933601/ https://www.ncbi.nlm.nih.gov/pubmed/31921698 http://dx.doi.org/10.3389/fonc.2019.01458 |
Ejemplares similares
-
Therapeutic targeting of ATR in alveolar rhabdomyosarcoma
por: Dorado García, Heathcliff, et al.
Publicado: (2022) -
Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies
por: Zarrabi, Ali, et al.
Publicado: (2023) -
Human Rhabdomyosarcoma Cell Lines for Rhabdomyosarcoma Research: Utility and Pitfalls
por: Hinson, Ashley R. P., et al.
Publicado: (2013) -
Doxorubicin Changes the Spatial Organization of the Genome around Active Promoters
por: Stefanova, Maria E., et al.
Publicado: (2023) -
Locally Advanced Cancer of the Esophagus, Current Treatment Strategies, and Future Directions
por: Rahma, Osama E., et al.
Publicado: (2012)